No evidence for substrate accumulation in Parkinson brains with GBA mutations.
about
The relationship between glucocerebrosidase mutations and Parkinson diseaseMitochondrial dysfunction associated with glucocerebrosidase deficiencyLipid profiling of parkin-mutant human skin fibroblasts.Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysisParkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models.Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models.Endoplasmic reticulum and lysosomal Ca²⁺ stores are remodelled in GBA1-linked Parkinson disease patient fibroblasts.GBA mutations in Parkinson disease: earlier death but similar neuropathological features.Current disease modifying approaches to treat Parkinson's disease.Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.Glucocerebrosidase in Parkinson's disease: Insights into pathogenesis and prospects for treatment.Sphingolipids: membrane microdomains in brain development, function and neurological diseases.Glucocerebrosidase Mutations in Parkinson Disease.Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein.Molecular mechanisms of α-synuclein and GBA1 in Parkinson's disease.The contribution of mutant GBA to the development of Parkinson disease in Drosophila.
P2860
Q28077257-37444F07-3C62-4AAF-987D-AE45436F0902Q28115678-6C440EB4-7FB9-4438-8FF8-36931FCC023AQ36256274-1F03349B-8AFA-426E-AB44-029C0DA87A09Q36284241-A6655FF9-4051-45A3-BAEA-4B4950647030Q37189019-75A6E1DF-DBE3-483B-B8FB-B3753B6BC2EBQ37696004-EFFDF2EB-95A4-4109-9C5B-EE2021FF55F0Q38389995-612AEA4D-086D-419C-AB36-0221CEC8D305Q38611816-CA90FFCF-506B-4E91-8FAA-96686CCF6DB7Q38652153-AA980737-E571-4698-9FA7-98DB14496E4BQ38727638-E58FC83F-7AA7-443B-9046-2F30D636097BQ38811401-02BAB6A8-51E6-40C1-8511-63C93CFF20CCQ39342245-A99525AF-2F88-4A24-A87E-39E34622B982Q39362339-A60A9F34-813C-4CAA-B4EF-EB6E1A197374Q40196691-E8B998C3-AB51-4AFF-BC05-A904190993EBQ46249781-CCF1D4C4-518C-46ED-8E0A-647CCD654D58Q47611385-262ED211-6927-44A0-B605-C6792EF31E66Q52848620-E3E11ECD-7BAA-42F2-B48F-A0685953D87F
P2860
No evidence for substrate accumulation in Parkinson brains with GBA mutations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
No evidence for substrate accumulation in Parkinson brains with GBA mutations.
@en
No evidence for substrate accumulation in Parkinson brains with GBA mutations.
@nl
type
label
No evidence for substrate accumulation in Parkinson brains with GBA mutations.
@en
No evidence for substrate accumulation in Parkinson brains with GBA mutations.
@nl
prefLabel
No evidence for substrate accumulation in Parkinson brains with GBA mutations.
@en
No evidence for substrate accumulation in Parkinson brains with GBA mutations.
@nl
P2093
P2860
P356
P1433
P1476
No evidence for substrate accumulation in Parkinson brains with GBA mutations.
@en
P2093
Bing H Wang
Lamya S Shihabuddin
Lindsay Sweet
Sergio Pablo Sardi
P2860
P304
P356
10.1002/MDS.26278
P407
P577
2015-06-11T00:00:00Z